[1]
P. S. Sv, M. M. A. Baig, A. Irfana, A. K. Fariha, and B. Fatima, “A STUDY OF THERAPEUTIC RESPONSE AND ADVERSE EFFECTS OF INTRAVENOUS ERYTHROPOIETIN VERSUS SUBCUTANEOUS ERYTHROPOIETIN ON HEMODIALYSIS PATIENTS IN THE DEPARTMENT OF NEPHROLOGY OF OHRC”, Int J Pharm Pharm Sci, vol. 9, no. 8, pp. 151-153, Aug. 2017.